Immunosuppressants and Prednisone in Pemphigus Vulgaris: Therapeutic Results Obtained in 63 Patients Between 1961 and 1975

Archives of Dermatology

Volumn 113, Issue 9, 1977, Pages 1236-1241

  Lever, Walter F ^a   Schaumburg Lever, Gundula ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DELTADANE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE; SERVISONE; UNCLASSIFIED DRUG;

ABSCESS; ADVERSE DRUG REACTION; CONTROLLED STUDY; DRUG COMPARISON; FATALITY; HEART INFARCTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PEMPHIGUS VULGARIS; PERITONITIS; SEPSIS; THERAPY;

ADULT; AGED; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGE; PEMPHIGUS; PREDNISONE; RECURRENCE;

EID: 0017700438     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1977.01640090084013     Document Type: Article

References (19)

1. 1. Lever WF: Methotrexate and prednisone in pemphigus vulgaris: Therapeutic results obtained in 36 patients between 1961 and 1970. Arch Dermatol 106:491-497, 1972.
2. 2. Lever WF, White H: Treatment of pemphigus with corticosteroids: Results obtained in 46 patients over a period of 11 years. Arch Dermatol 37:12-26, 1963.
3. 3. Rosenberg FR, Sanders S, Nelson CT: Pemphigus: A 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 112:962-970, 1976.
4. 4. Krain LS: Pemphigus: Epidemiologic and survival characteristics of 59 patients, 1955-1973. Arch Dermatol 110:862-865, 1974.
5. 5. Wolff K: Immunosuppressive Therapic bullöser Dermatosen. Hautarzt, suppl 1,1976, pp 25-27.
6. 6. Lever WF, Goldberg HS: Treatment of pemphigus vulgaris with methotrexate. Arch Dermatol 100:70-78, 1969.
7. 7. Peck SM, Osserman KE, Samuels AJ, et al: Studies in bullous diseases. Arch Dermatol 103:141-147, 1971.
8. 8. Ebringer A, Mackay IR: Pemphigus vulgaris successfully treated with cyclophosphamide. Ann Intern Med 71:125-127, 1969.
9. 9. McKelvey EM, Hasegawa J: Cyclophosphamide and pemphigus vulgaris. Arch Dermatol 103:198-200, 1971.
10. 10. Krain LS, Landau JW, Newcomer VD: Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 106:657-661, 1972.
11. 11. Wolff K, Schreiner E: Immunosuppressive Therapie bei Pemphigus vulgaris. Arch Klin Exp Dermatol 235:63-77, 1967.
12. 12. Krakowski A, Covo J, Rozanski Z: Pemphigus vulgaris. Arch Dermatol 100:117, 1969.
13. 13. Van Dijk TJA, van Velde JL: Treatment of pemphigus and pemphigoid with azathioprine. Dermatologica 147:179-185, 1973.
14. 14. Burton JL, Greaves MW: Azathioprine for pemphigus and pemphigoid: A four-year follow-up. Br J Dermatol 91:103-109, 1974.
15. 15. Ryan JG: Pemphigus. A 20-year survey of experience with 70 cases. Arch Dermatol 104:14-20, 1971.
16. 16. Jablonska S, Chorzelski T, Blaszczyk RM: Immunosuppressants in the treatment of pemphigus. Br J Dermatol 83:315-323, 1970.
17. 17. Roenigk HH Jr, Deodhar S: Pemphigus treated with azathioprine. Arch Dermatol 107:353-357, 1973.
18. 18. Penneys NS, Eaglstein WH, Indgin S, et al: Gold sodium thiomalate treatment of pemphigus. Arch Dermatol 108:56-60, 1973.
19. 19. Penneys NS, Eaglstein WH, Frost P: Management of pemphigus with gold compounds: A long-term follow-up report. Arch Dermatol 112:185-187, 1976.